Drug-coated balloons

Original Contribution

Outcomes Following Coronary Chronic Total Occlusion Revascularization With Drug-Coated Balloons

02/21/2024

Yuan Zhi , MD;

Vanessa Bade , BSc;

Adrian Attinger-Toller , MD;

Florim Cuculi , MD;

Irena Majcen , PhD;

Mathias Wolfrum , MD;

Stefan Toggweiler , MD;

Giacomo M. Cioffi , MD;

Federico Moccetti , MD;

Francesco Ferraro , MD;

Mehdi Madanchi , MD;

Eleonora Gnan , MD;

Matthias Bossard , MD;

Varis Gjergjizi , MD;

The study aimed to describe the safety and long-term outcomes of patients with coronary chronic total occlusions undergoing percutaneous coronary interventions with the latest generation of drug-coated balloons vs novel drug-eluting stents.

The study aimed to describe the...

02/21/2024

Journal of Invasive Cardiology

AMP 2023

Current Clinical Data on RANGER DCB: RANGER II SFA, COMPARE, and Real-World Experience with ELEGANCE

11/13/2023

Pradeep K. Nair , MD, FACC, FSCAI;

In this video recorded at AMP 2023, Dr. Pradeep Nair discusses his presentation on the clinical data available on the Ranger drug-coated balloon.

In this video recorded at AMP...

11/13/2023

Vascular Disease Management

AMP 2023

The Value of Debulking and Vessel Prep Before Drug Delivery

11/09/2023

Craig M. Walker , MD, FACC, FACP, FSCAI, FCCP;

Dr. Craig Walker, from the Cardiovascular Institute of the South in Houma, Louisiana, discusses his presentation on using vessel prep before drug-coated balloon delivery.

Dr. Craig Walker, from the...

11/09/2023

Vascular Disease Management

Commentary

The Paclitaxel-Coated Conundrum: A Commentary Article

01/14/2020

Michael Patel , MD;

Robert E. Beasley , MD, FSCAI, FSIR;

Michael Patel, MD, and Robert Beasley, MD discuss drug-eluting stents and drug-coated balloons.

Michael Patel, MD, and Robert...

01/14/2020

Vascular Disease Management

FDA Panel

The Future is Going to Be Drug-Coated or Drug-Eluting. We Need Individual Patient Data to Move Forward.

06/27/2019

Konstantinos Katsanos , MSc, MD, PhD;

VDM talks with Konstantinos Katsanos, MSc, MD, PhD, EBIR, Assistant Professor, Interventional Radiology, School of Medicine, Patras University Hospital, Patras, Greece.

VDM talks with Konstantinos...

06/27/2019

Vascular Disease Management

FDA Panel

A View on Drug-Coated Balloons From the Land of the Practicing Physician

06/21/2019

Jihad A. Mustapha , MD, FACC, FSCAI;

Jihad A. Mustapha, MD, comments on the use of drug-coated balloons.

Jihad A. Mustapha, MD, comments...

06/21/2019

Vascular Disease Management

Original Contribution

Outcomes With Drug-Coated Balloons for Treating the Side Branch of Coronary Bifurcation Lesions

09/15/2018

Michael Rofael , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Michael S. Megaly , MD, MS;

Marwan Saad , MD, PhD, MS;

Mehdi H. Shishehbor , DO, MPH, PhD;

We performed a systematic review of all studies published between January 2000 and February 2018 reporting the outcomes of DCB vs non-coated balloon angioplasty (BA) in the treatment of the SB in coronary bifurcation lesions. Outcomes...

We performed a systematic review...

09/15/2018

Journal of Invasive Cardiology

Review

Should We Routinely Stent the Femoropopliteal Artery? An Interventionalist`s Perspective

11/01/2015

Nicolas W. Shammas , MD, MS, FACC, FSCAI, FACP, FSVM;

Subhash Banerjee , MD, FSCAI;

An overview of the pros and cons of primary stenting of femoropopliteal (FP) arteries vs alternative approaches including provisional stenting following POBA, atherectomy and/or drug-coated balloons.

An overview of the pros and cons...

11/01/2015

Journal of Invasive Cardiology

Review

Drug-Eluting Stents and Drug-Coated Balloons in Peripheral Interventions

11/06/2008

Thomas Zeller, MD

Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany

Thomas Zeller, MD Herz-Zentrum Bad K...

In the coronaries, the role of drug-eluting stents (DES) is already well defined. However, in the peripheral arteries very limited data exists about their potential benefit.

In the coronaries, the role of...

11/06/2008

Vascular Disease Management